हिंदी में पढ़ें
Income Tax Calculator
Personal Loan Calculator
Car Loan Calculator
Home Loan Calculator
MF Returns Calculator
Glenmark Pharmaceuticals News
Top Stocks To Buy Today: Bajaj Finance, Glenmark Pharma, PNC Infra to Sterlite Technologies - 20 shares to earn bumper returns
Mon, Aug 17, 2020
Stocks To Buy Today: As we begin a new week with hopes of earning good money after a negative closing on Friday, it is important for investors to know what may work for them today. Zee Business brings a list of 20 such stocks which have the potential to earn bumper returns
Glenmark initiates Phase 3 clinical trials on Favipiravir to check efficacy on COVID-19 patients
Tue, May 12, 2020
Glenmark Pharmaceuticals on Tuesday said it has initiated Phase 3 clinical trials on antiviral drug Favipiravir to check its efficacy on COVID-19 patients in India
Glenmark Pharma gets USFDA nod for cholesterol lowering drug
Fri, Jun 28, 2019
Glenmark Pharmaceuticals Friday said it has received final approval from the US health regulator for Ezetimibe and Simvastatin tablets, used for treating high levels of cholesterol in the blood.
Top 5 stocks in focus on August 8: Glenmark, Merck to Techno Electric, here are the 5 newsmakers of the day
Wed, Aug 08, 2018
Glenmark Pharmaceuticals has received final approval from the US health regulator, USFDA, for Colesevelam Hydrochloride for oral suspension, used to lower cholesterol levels in the blood. The approved product is a generic version of Daiichi Sankyo Inc’s Welchol.
From HCL Tech, Maruti Suzuki to PVR, here are 5 stock picks for the week
Sun, Jun 10, 2018
CPI, WPI and IIP will be presented in upcoming week and domestic indices will move as per the performances of these indicators.
Glenmark share price hits 52-week low, tanks 9% post Q4 FY18 results
Wed, May 30, 2018
Glenmark said results are not comparable to the corresponding quarter of the previous year, as the company through its partner Endo had launched Ezetimibe in the US in December 2016 and was entitled to an exclusivity on the product.
How Glenmark Pharma won this Candid Powder battle against lookalike rival
Thu, May 24, 2018
Pharma company Glenmark Pharmaceuticals, which manufactures and sells Candid Dusting Powder, has recently won a trademark and copyright battle in the Bombay High Court, against a lookalike brand, which sold a dusting powder by the name ‘Candidat’.
Post GST domestic pharma companies to face headwinds in 1HFY18
Mon, Jun 05, 2017
It has been a long and dreary quarter for pharmaceutical companies in Q4 wherein most posted a decline in net profit and things are not looking too good for the Indian pharma companies in the first half of FY18 as well.
Glenmark Pharmaceuticals receives ANDA approval for Atomoxetine capsule
Wed, May 31, 2017
The Glenmark Pharmaceuticals has been granted permission by the United States Food & Drug Administration (U.S. FDA) for Atomoxetine capsules.
Glenmark receives tentative approval Fingolimod Capsules; shares down
Mon, Mar 20, 2017
Glenmark’s current portfolio consists of 112 products authorized for distribution in the US marketplace.
Glenmark Pharma's Q3 net profit rise by 143% to Rs 477 crore
Thu, Feb 02, 2017
The company's total income increased to Rs 2549.5 crore in Q3FY17 as compared to Rs 1780.4 crore in Q3FY16.
India Inc's overseas borrowings down 44% to $1.2 billion in July
Fri, Aug 26, 2016
India Inc's overseas borrowings fell by 44% to $1.2 billion (nearly Rs 7,983.3 crore) in July this year as against $2.14 billion (nearly Rs 14,236.9 crore) in the same period a year ago.
Glenmark Pharma net profit rise 24%; Europe segment major contributor
Fri, Aug 12, 2016
Glenn Saldanha, Chairman & MD, Glenmark Pharmaceuticals said, “In the first quarter of this financial year, nearly all our businesses have rebounded strongly and we have seen good growth across all operating regions except Latam.